
Trump's Game-Changing Move: Cannabis Set for Major Policy Overhaul
Expect a seismic shift in US drug policy as President Trump prepares to reclassify cannabis from a Schedule I narcotic to a Schedule III drug, aligning it with medications like Tylenol with codeine. This pivotal change promises to open new doors for research and regulation, but not without controversy.
Read full article




























